Supplementary Figure S3 from Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells
Abstract
Supplementary Figure S3, related to Figure 3. Synergistic cancer cells have unique transcriptional, proteomic and mutational characteristics.
Fields of Study & Subjects
PARP inhibition in cancer therapy
RNA regulation and disease
Nuclear Receptors and Signaling
Publication details
- Publication date
- 2 January 2026